Literature DB >> 12554828

Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.

Christian R Dolder1, Jonathan P Lacro, Dilip V Jeste.   

Abstract

OBJECTIVE: The prevalence and consequences of nonadherence to antipsychotic medications in schizophrenia and related psychotic disorders have been well described; however, little is known about adherence to medications for nonpsychiatric conditions in patients with psychotic disorders. We wished to determine medication adherence in nondemented middle-aged and older Veterans Affairs outpatients with schizophrenia or other psychotic disorders who had been prescribed oral medications for hypertension, hyperlipidemia, or diabetes.
METHODS: Medication adherence was assessed by review of medication fill records for 76 patients aged 40 years and older who had been prescribed an oral antipsychotic in addition to an oral agent for hypertension (N = 60), hyperlipidemia (N = 28), or diabetes (N = 24). Up to 12 months of therapy was reviewed, and a compliant fill rate (the number of adherent fills in proportion to the total number of prescription fills) and cumulative mean gap ratio (the number of days when medication was unavailable in relation to the total number of days) were calculated for each medication.
RESULTS: The 12-month mean compliant fill rates for antipsychotics, antihypertensives, antihyperlipidemics, and antidiabetics ranged from 52% to 64%. Nonpsychiatric medication adherence rates were similar in patients on typical vs. atypical antipsychotics and did not correlate significantly with antipsychotic adherence rates.
CONCLUSIONS: Nonadherence rates were found to be equally problematic for both antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Interventions to improve adherence to both antipsychotic and nonpsychiatric medications are needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554828     DOI: 10.1097/01.psy.0000040951.22044.59

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  16 in total

1.  Adherence to Psychotropic and Nonpsychotropic Medication Among Patients With Bipolar Disorder and General Medical Conditions.

Authors:  Jennifer B Levin; Michelle E Aebi; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic
Journal:  Psychiatr Serv       Date:  2015-12-15       Impact factor: 3.084

2.  Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness.

Authors:  Ashli Owen-Smith; Christine Stewart; Carla Green; Brian K Ahmedani; Beth E Waitzfelder; Rebecca Rossom; Laurel A Copeland; Gregory E Simon
Journal:  Gen Hosp Psychiatry       Date:  2015-07-30       Impact factor: 3.238

3.  A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness.

Authors:  Julie Kreyenbuhl; Jaclyn Leith; Deborah R Medoff; Lijuan Fang; Faith B Dickerson; Clayton H Brown; Richard W Goldberg; Wendy Potts; Lisa B Dixon
Journal:  Psychiatry Res       Date:  2011-04-02       Impact factor: 3.222

4.  Extended release drug delivery strategies in psychiatry: theory to practice.

Authors:  Steven J Siegel
Journal:  Psychiatry (Edgmont)       Date:  2005-06

5.  Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency.

Authors:  Todd P Gilmer; Victoria D Ojeda; Concepcion Barrio; Dahlia Fuentes; Piedad Garcia; Nicole M Lanouette; Kelly C Lee
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

6.  Medication adherence among older adults with schizophrenia.

Authors:  Heather C Leutwyler; Patrick J Fox; Margaret Wallhagen
Journal:  J Gerontol Nurs       Date:  2013-01-18       Impact factor: 1.254

7.  Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?

Authors:  Julie Kreyenbuhl; Lisa B Dixon; John F McCarthy; Soheil Soliman; Rosalinda V Ignacio; Marcia Valenstein
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

Review 8.  [Psychiatric pharmacotherapy of older individuals with severe mental illness].

Authors:  Christian Lange-Asschenfeldt
Journal:  Z Gerontol Geriatr       Date:  2018-10-09       Impact factor: 1.281

9.  Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic.

Authors:  Ankit Jain; Kamal Kant Sahu; Paroma Mitra
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes.

Authors:  Jennifer M Aakre; Deborah R Medoff; Lisa B Dixon; Julie A Kreyenbuhl
Journal:  Patient Prefer Adherence       Date:  2012-05-09       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.